The Latest Breaking News from TLRY

The pharmaceutical sector performs relatively well during economic uncertainties due to inelastic demand for its products and services. While prominent players Tilray Brands (TLRY) and Novo Nordisk (NVO) should benefit, which stock is the better buy now? Read more to find out.

Canadian cannabis leader Tilray Brands (TLRY) is bolstering its portfolio through expansions and partnerships. However, the company’s recent $150 million offering of senior notes put pressure on its stock price. Would it be wise to buy the stock now? Let’s look at its financial metrics to answer that….

Despite legalization gaining traction, the cannabis industry's prospects for the year ahead remain grim due to several economic and industry-wide headwinds. As a result, it seems wise to avoid sinking cannabis stocks Curaleaf Holdings (CURLF), Tilray Brands (TLRY), and Verano Holdings (VRNOF). Read more….

The cannabis industry has been facing several economic and regulatory challenges. Demand has also slowed amid a glut in supply. With the Fed unlikely to stop interest rate hikes, the economy could enter a recession this year. Amid this backdrop, it could be wise to avoid fundamentally weak cannabis stocks…

Despite significant growth in recent years driven by increased legalization, the cannabis industry took a hit last year amid economic and industry-wide headwinds, including stubborn supply gluts. Furthermore, the industry will likely remain under pressure this year due to economic challenges. Hence, it could be wise to avoid fundamentally weak…

Despite the banking industry crisis, the Fed is expected to launch another rate hike next week as it remains committed to bringing inflation down. Therefore, fundamentally weak stocks Snap (SNAP), Peloton Interactive (PTON), and Tilray Brands (TLRY) might be best avoided as they might plunge further. Keep reading.

Following remarkable growth in recent years, the cannabis industry faced various legal and economic challenges, including overproduction amid high inflation, high taxes, and increased material costs impacting overall sales in 2022. The industry will likely remain under pressure amid concerns over rising inflation and a potential recession. Hence, it could…

The cannabis industry faced several challenges last year, including overproduction amid high inflation weighing on overall demand. With growing concerns over rising inflation and a looming recession, the industry is expected to remain under immense pressure this year. So, it could be wise to avoid fundamentally weak cannabis stocks Tilray…

Although several states have legalized marijuana, the industry faces a supply glut amid high inflation impacting overall demand. With Federal legalization unlikely this year, marijuana stocks could remain under pressure. Therefore, would it be wise to invest in marijuana stocks Tilray Brands (TLRY), Canopy Growth (CGC), and Aurora Cannabis (ACB)…

Soaring concerns over an impending Fed-induced recession have hampered investor sentiment. With the likelihood of a downturn in upcoming months, are popular stocks Peloton Interactive (PTON), Tilray Brands (TLRY), and ContextLogic (WISH) worth your attention? Read on to find out….

The marijuana industry took a hit facing economic challenges. With no immediate hope of federal legalization, it may be a while until the U.S. government looks favorably toward pot stocks. Hence, fundamentally weak marijuana stocks Tilray Brands (TLRY) and Canopy Growth (CGC) might be best avoided this year. Continue reading….